Prosecution Insights
Last updated: October 01, 2026
Application No. 18/971,532

Control Console And Accessories For RF Nerve Ablation And Methods Of Operating The Same

Non-Final OA §102§112
Filed
Dec 06, 2024
Priority
Apr 28, 2017 — provisional 62/491,615 +3 more
Examiner
PEFFLEY, MICHAEL F
Art Unit
Tech Center
Assignee
Stryker Corporation
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
1y 7m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
1074 granted / 1380 resolved
+17.8% vs TC avg
Moderate +13% lift
Without
With
+13.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
28 currently pending
Career history
1406
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
38.3%
-1.7% vs TC avg
§102
24.5%
-15.5% vs TC avg
§112
15.7%
-24.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1380 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 16 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 16 lacks proper antecedent basis for “the cable accessory” and for “the one or more electrode attachments”. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jackson et al (5,383,874). Regarding claim 1, Jackson et al provide a control console configured for ablation (Figure 1, it is noted the device is inherently capable of ablating nerves) comprising a display (Figure 1), an interface configured to receive attachments for RF ablation (figure 1) and to facilitate connection between a memory device of each attachment (i.e. catheter) and the controller. Each memory device has a unique identification code to identify the device and is usage data (Abstract). A controller is coupled to the display and the interface and is configured to read and store the identification code and usage data associated with the attachment (i.e. catheter) received at the interface, process the stored identification code and usage data, and generate a digital representation of the processed identification and usage data on the display. See, for example, columns 6 through 9 which discloses the use of a memory component on each catheter device, the reading of the code, including usage data, the storing of the identification and usage data and the display of processed identification and usage data (e.g. “Use Not Permitted”). Regarding claim 2, the control console is configured to read and store the identification and usage data at different times to generate a cumulative database of the stored data (col. 7, lines 44-67 and col. 8, line 59 to col. 9, line 24). Regarding claim 3, the controller is configured to process the stored identification code and usage data in the cumulative database (e.g. look-up table). Regarding claim 4, each memory device has a stored authentication data associated with authorization of use of the device (col. 7, lines 7-55, for example). Regarding claim 5, the attachments (i.e. catheters) are an electrode attachment (e.g. catheters having electrodes). Regarding claim 6, the attachments (i.e. catheters) are a cable accessory configured to interconnect one or more electrode attachments to the control console. That is, the cable accessory is the memory carried within the handle (which is attached to the cable) and interconnects one or more electrodes on the catheter to the control console. Regarding claim 7, the usage data is associated with the usage of the cable accessory (i.e. counts the number of uses). Regarding claim 8, the controller is configured to detect an operating error (e.g. unacceptable code or expired usage data) and associate the operating error with the identification data and generate the digital representation (e.g. “Use Permitted” or “Use Not Permitted”). Regarding claim 9, the controller is further configured to write usage data to the memory device (col. 9, lines 1-11, for example). Regarding claim 10, the controller is configured to retain the identification and usage data associated with the attachments in memory after the attachments are disconnected (e.g. “look-up table”). Regarding claim 11, there is an RF generator to generate RF signals to the attachments (i.e. catheters). Regarding claim 12, Jackson et al disclose a method for operating a control console configured for RF ablation, the console comprising a display, a controller and an interface configured to receive attachments (i.e. catheters) adapted for RF nerve ablation as addressed with respect to claim 1 above. Each attachment has a memory device (Abstract) having stored thereon identification data identifying the attachment and usage data (Abstract). The method comprises the steps of reading the identification and usage data, storing the identification and usage data, processing the stored data and generating a digital representation of the processed data provided to the display. See, for example, columns 6-9 of Jackson et al which discloses each of these features. Regarding claim 13, the identification and usage data is updated each time the device is attached (i.e. at different times) and the storing of the data is updated each time the device is attached to create a cumulative database that includes a look-up table and a running tab of the number of uses of the device. Regarding claim 14, the data is organized in the cumulative database (e.g. look-up table and use criteria table which tracks the number of uses). Regarding claim 15, each memory device has stored thereon authentication data associated with authorization of use of the attachment (i.e. catheter, as disclosed at column 7, lines 7-55). Regarding claim 16, the usage data is associated with usage of the cable accessory with the control and/or usage of the accessory (i.e. memory) with the one or more electrode attachments. Regarding claim 17, the control console also detects an operating error (e.g. an unacceptable code or an excessive number of uses) and generates an operating error for the display (e.g. “Use Not Permitted”). Regarding claim 18, the control console also writes usage data to the memory device (col. 9, lines 1-16, for example). Regarding claim 19, the console has a memory that stores identification and usage data associated with the attachments (i.e. look-up table entry for each device). Regarding claim 20, the control console includes an RF generator for delivering RF energy to the attachments (i.e. catheters). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Denen et al (5,400,267) discloses another RF device having a memory chip to identify the device that is attached to a treatment console. In particular, Denen et al teach the memory chip may be provided in the device (Figure 1) or in a cable accessory (Figure 2) for attachment to the device and the treatment console. Panescu et al (6,165,169) and Qin et al (6,464,689) disclose other systems that provide an identification means on devices for use with the system. Both Panescu et al and Qin et al provide a display as well as a memory means to track the devices being connected to the system and the amount of usage of the attached devices. Edwards et al (7,122,031) disclose another system that may attach a variety of devices to the display/console, and specifically teach the device may be used to ablate nerve tissue (col. 23, lines 13-25, for example). Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL PEFFLEY whose telephone number is (571)272-4770. The examiner can normally be reached Mon-Fri 8 am-5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at (571) 272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL F PEFFLEY/Primary Examiner, Art Unit 3794 /M.F.P/September 8, 2026
Read full office action

Prosecution Timeline

Dec 06, 2024
Application Filed
Sep 11, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740823
RADIO FREQUENCY CATHETER CONTROLLING SYSTEM AND METHOD
2y 4m to grant Granted Sep 22, 2026
Patent 12740822
THERMAL CUTTING ASSEMBLY WITH CONDUCTIVE BRIDGE
1y 11m to grant Granted Sep 22, 2026
Patent 12733970
RF ABLATION SYSTEMS WITH A BIPOLAR RF ELECTRODE AND METHODS FOR MAKING AND USING
2y 11m to grant Granted Sep 15, 2026
Patent 12734065
MEDICAL COOLING DEVICE AND COOLING METHOD USING THE SAME
2y 4m to grant Granted Sep 15, 2026
Patent 12733971
INTEGRATED SURGICAL SYSTEM
2y 2m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
91%
With Interview (+13.0%)
3y 5m (~1y 7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1380 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month